건강 r&d’를 위한 기초의과학 연구 생태계htforum.mlive.kr/20131206/pdf/02.pdf ·...
TRANSCRIPT
Contents
II. A Quick Look into the Future Trends
2
III. 한국연구재단 기초 및 원천연구사업
I. 창조경제와 기초연구
V. 세계를 선도하는 우리 R&D
IV. HT관련 융합 R&D - 무엇이 문제인가?
4
"The creative economy is led by the private sector. The government will set up a safety network and make a helpful environment where enterprises can take on challenges by overcoming failure and rewarding good ideas.“ – <民間(企業) 主導 – 政府 後方支援> "Undergoing many failures is inevitable in successfully realizing a creative economy, just like the weed whose effectiveness has not been proven yet.“ – <誠實失敗 容認 및 救濟 制度> "To achieve creative economy, globalization is vital. We should consider the markets on a global level and cooperate with people around the world.“ – <市場 및 人力의 國際化 世界化> "Flowers of creativity blossom across the borderline. Through the creative economy, traditional businesses will be reborn as new higher value-added businesses and high-tech industries will lead the future.“ - <融合 – 傳統産業과 創造企業>
Key Words of Park’s Government’s Creative Economy
Key words: Job Creation, ICT, S&T, Convergence/Integration, Globalization, Humanities/Arts, Private Sector Leading
Organization Chart
Examples of ‘Creative’ Industries - Advertising - Music
- Animation - Performing Arts
- Architecture - Arts and Crafts
- Publishing - Software and Computer Services
- Design & Fashion - TV and Radio
- Film - Video and Computer Game
What is Creative Economy? - Its Industries and Markets
[ Dept. for Culture, Media and Sport, UK, 1998 ]
5
Those activities which; - have their origin in individual idea, imagination, creativity, etc. - have the potential for job creation through the generation and
exploitation of intellectual property
A Model Cycling Process of “Creative Economy”
6
Academy-Industry Liaison
Innovation-driven Industries and/or
Start-ups
Job Creation
Tax Revenue
Creativity/New Ideas
Arts/Humanities ICT/S&T
Entrepreneurship
Recovery Net New Markets New Products New Services
II. A Look into the Future Trends
7
We need to incorporate those into
the policy-making for Creative Economy!
1. “시장”의 변화
- 고령화 사회에 따라 “ubiquitous” 하고 “POC” 기능의 “자가진단”
수요 급증
2. “패러다임”의 변화
- 생활수준의 향상, well-being 등에 따라 “질병치료”(Cure)로부터
“건강관리”(Care)로의 인식 변화
3. “기술”의 변화
- Genomics, proteomics 등 BT의 급격한 발전에 따라 혁신적, 고신뢰성
“biomarker” 들이 속속 발굴 활용
- ‘Cellular’ 정보통신용 NT/IT의 발전에 따른 mobile 소재 소자
보건의료(Healthcare)산업 환경의 변화 추세
Drugs get Smarter
Innovation vs. Knowledge
Power Patient Generation
예방의학 Shift to Personalised
Healthcare 맞춤의학 Prevention Before Cure
Patients become Customers
Healthcare globe trotters
Cyber Docs Hospitals go Virtual
Devices become monitors, monitors become devices
낮음 높음 확신도
Healthcare 분야 10대 글로벌 트렌드 (2007 – 2020)
낮음
높음
Healthcare 산업에 미치는
영향
Frost & Sullivan (2008)
미국 <미국혁신전략>
일본 <일본재흥전략>
독일 <하이테크 2020>
중국 <7대 신성장산업>
청정에너지 세계 최고 수준의 IT 기후/에너지 에너지절약/환경보호
바이오 건강수명 신장 보건/건강 차세대 정보기술
나노 청정/경제적인
에너지 정보통신 바이오
첨단제조업 사회 인프라 및
교통 이동(교통/항공/해양) 첨단장비제조
우주공학 고품질 농수산물 안전/보안 신에너지
의료기술 관광자원 - 신소재
교육기술 - - 신에너지 자동차
주요국의 중점 육성 전략산업(자료: NIPA)
Future Forecast of Health Science & Technology - Six Developments in the Next Era
‘2029 Project’ (IAF - Pfizer, Inc. - Johns Hopkins U.)
14
1. “Creative Convergence” - between Western medicine and Eastern healthcare
2. “Quantum Biology”
3. “Systems Biology” – Networks & Interactions
4. “New Personalized Medicine” – towards ‘Preventive Medicine’
5. “Wisdom Revolution” – Big data & Human-Non-human Interactions
6. “Health (not Healthcare) Technology” – towards Social Services & Wellness
Key Trends Towards the Future Society
“Decentralized” Society - Mobile & ‘Smart’ - Individualized - Consumerism & communication (through SNS)
Higher Standards of “EHS” (Environment/Energy-Health-Safety) - Wellbeing & wellness - ‘Societal safety/security net’
15
These trends should be fully understood and incorporated into the technology policies for Creative Economy!!
‘Creative’ Enterprises and Technologies, and How We Can Get There?
16
Creative innovations will come from slow and steady ‘evolution’,
not from sudden and abrupt ‘revolution’.
- Importance of “Basics”
Trend Enterprise Platform Technology
Decentralized (Smart)
SBE (SNS-Based Enterprises)
ICT (Information & Communication)
EHS WBE (Wellness-
Based Enterprises) BHT (Bio & Health)
Integration and Co-operation Between Traditional Industries and Creative Enterprises
Manufacturing
Industries
- Economy of scale
- Efficiency
Service
Industries
- Knowledge-based
- Satisfaction
SBE (ICT) WBE (BHT)
Traditional Industries
Creative Enterprises
Basic Research in Science & Engineering
Hum
anities &
Arts
예: 제약회사 예: 병원
18
Shift from ‘Technology-Push’ to ‘Market-Pull’
‘Integration & Convergence’ is essential – ‘Puzzle-solving’ approach
Strong leader & coordinator – “Steve Jobs”??
기초연구
개인연구
집단연구
일반 연구자
중견 연구자
리더 연구자 (창의/
국가과학자)
기초 연구실
선도연구센터 (ERC, SRC, NCRC,
MRC)
원천기술개발
사업단
글로벌 프론티어 사업
미래융합 파이오니어
사업
신기술융합형 성장동력사업
차세대 바이오사업
기술분야
바이오 의료
정보 컴퓨팅
나노 소재
공공복지 안전
기후변화 대응
첨단융합
해양극지 뇌과학
한국연구재단 기초 원천연구지원 사업구조
• Bottom-Up • Mostly Individual research ; Some small group research • Academic disciplines/ Research Articles, Patents
• Top-Down • Mostly Large Group research • Technologies/Patents/ Tech transfers
Ⅲ. About NRF
Natural Sciences
Medical & Pharmaceutical
Sciences
Electrical & Information Engineering
and Convergence
Research
Basic Research
Management
Life Sciences
Directorate for Basic Research in
Science and Engineering
Engineering Sciences
24
Basic Research Infrastructure
- Creative Research
- National Scientist
Supporting Small-scale Research Groups formed around specific research topics 4~5 faculty members 5yrs, 500 mil KRW
Developing Global Research Leaders Rigorous Evaluation System 9~10yrs, 500~1,500 mil KRW
- Core Research - National Research Lab.
- General Individual Researchers - Young Researchers - Women Scientists - Scientists in Local Universities
Creative, Challenging Research Bottom-up, Middle-up & down 3yrs, 100~300 mil KRW
Grassroots Research, Young Researchers Simplified Evaluation 3yrs, 50~250 mil KRW
Next-generation Researchers Key Research Institute Research Information Lab. Data Hub
Enhancing Research Capacity of New Ph.D.’s
Reinforcing Support for University Research
Infrastructure
Shared Utilization of Professional Research
Information
Building Infrastructure for Sharing & Analyzing Large-Capacity Data
1~5yrs, 33~150 mil KRW 9yrs, 600 mil KRW 5yrs, 170 mil KRW 5yrs, 2500 mil KRW
Grouping High-quality Researchers according to Specific Goals and Fields About 10 faculty members 7-9yrs, 500-2,000 mil KRW
II. Outline of Basic Research Programs
- Science/Engineering Research Center - Medical Research Center - National Core Research Center
2013년도 의학 RB분야
생리학
생화학
미생물/기생생물학
해부/병리/법의학
면역학
약리학
종양학
신경/정신과학
소화기/감염/호흡기/소아과학/류마티스/알레르기학
가정의학/내분비/신장/심혈관학
진단검사의학/영상의학/핵의학/방사선종양학
외과학/성형외과학/신경외과학/흉부외과학
/정형외과학/마취과학/응급의학/재활의학
비뇨기과학/산부인과학
안과학/이비인후과학/피부과학
예방의학/직업환경의학
○신청: 86개 / ●선정: 16개
○신청: 228개 / ●선정: 33개
○신청: 81개 / ●선정: 15개
○신청: 129개 / ●선정: 25개
○신청: 190개 / ●선정: 39개
○신청: 223개 / ●선정: 43개
○신청: 218개 / ●선정: 38개
○신청: 81개 / ●선정: 15개
○신청: 94개 / ●선정: 18개
○신청: 224개 / ●선정: 39개
○신청: 62개 / ●선정: 8개
○신청: 233개 / ●선정: 45개
○신청: 205개 / ●선정: 33개
○신청: 175개 / ●선정: 34개
○신청: 258개 / ●선정: 46개
기초-임상연구 연계 강화 글로벌 학문분류 반영 질환 기전 및 병인 연구 위주
2013년도 의학 RB분야
생리학
생화학
미생물/기생생물학
해부/병리/법의학
면역학
약리학
종양학
신경/정신과학
소화기/감염/호흡기/소아과학/류마티스/알레르기학
가정의학/내분비/신장/심혈관학
진단검사의학/영상의학/핵의학/방사선종양학
외과학/성형외과학/신경외과학/흉부외과학
/정형외과학/마취과학/응급의학/재활의학
비뇨기과학/산부인과학
안과학/이비인후과학/피부과학
예방의학/직업환경의학
분자세포 의학
감염 의학
면역 의학
인체시스템 의학
약리 의학
재생 의학
종양 의학
신경 의학
정신 의학
소화기 의학
대사/내분비 의학
심혈관/신장/호흡기 의학
병리/진단 의학
방사선 의학
근골격계/외상/재활 의학
유전생식발달의학
감각기능의학
예방 및 직업환경 의학
2014년도 의학 RB분야(안)
기초 의학
응용의학
약학대학 신설(20개 → 35개) 약학분야 연구 수요 팽창
2013년도 약학 RB분야
생물기반 약학
화학기반 약학
일반 약학
2014년도 약학 RB분야(안)
생물약학
화학합성약학
제약 및 약제학
천연물약학
분석약학 및 사회약학
31
‘Death Valley’??
32
Shift from ‘Technology-Push’ to ‘Market-Pull’
‘Integration & Convergence’ is essential – ‘Puzzle-solving’ approach
Strong leader & coordinator – “Steve Jobs”??
융합연구 성공 조건
1. Consensus on Benefits of Integration
2. Open Mind & Mutual Respect
3. Strong Leadership
4. Credit Sharing System
임상의학자들의 융합연구 참여 활성화 방안
문제점
• ‘Peer Pressure’ • 병원 수익
• 논문실적 부족
• 연구성과 평가 다양화
해결 방안
• 연구중심병원 등 통한 연구장려 제도 구축
• 임상의사 주도 연구과제 경우 간접비 대폭 상향 조정
• 논문실적 우수한 기초생명과학자들과의 협동 융합연구 장려 (예: 과제 선정 시 가점 부여
• SCI 논문 외 신의료기술 등록, 특허, 기술이전
등 다양한 연구성과 인정
U.S. 1 ○ CHINA 2 ○ INDIA 3 ○ JAPAN 4 ○
GERMANY 5 ○ RUSSIAN FEDERATION 6 ○
BRAZIL 7 ○ U.K. 8 ○
FRANCE 9 ○ MEXICO 10 ○
ITALY 11 ○ KOREA 12 ○
CANADA 13 ○ SPAIN 14 ○
INDINESIA 15 ○ TURKEY 16 ○
AUSTRALIA 17 ○ POLAND 18 ○
NETHERLANDS 19 ○ SOUTH AFRICA 20 ○
○ 1 ISRAEL 4.38% ○ 2 KOREA 4.03% ○ 3 FINLAND 3.78% ○ 4 JAPAN 3.39% ○ 5 SWEDEN 3.37% ○ 6 DENMARK 3.09% ○ 7 TAIWAN 3.02% ○ 8 GERMANY 2.88% ○ 9 U.S. 2.77% ○ 10 AUSTRIA 2.75% ○ 11 SLOVENIA 2.47% ○ 12 ESTONIA 2.41% ○ 13 FRANCE 2.24% ○ 14 SINGAPORE 2.23% ○ 15 BELGIUM 2.04% ○ 16 CZECH REPUBLIC 1.85% ○ 17 CHINA 1.84% ○ 18 U.K. 1.77% ○ 19 CANADA 1.74% ○ 20 IRELAND 1.70% ○ 21 NORWAY 1.66% ○ 22 PORTUGAL 1.49% ○ 23 LUXEMBOURG 1.43% ○ 24 SPAIN 1.33% ○ 25 NEW ZEALAND 1.30% ○ 26 ITALY 1.25% ○ 27 HUNGARY 1.21% ○ 28 RUSSIAN FEDERATION 1.09% ○ 29 TURKEY 0.86% ○ 30 POLAND 0.76% ○ 31 SLOVAK REPUBLIC 0.68% ○ 32 ARGENTINA 0.65% ○ 33 ROMANIA 0.50% ○ 34 MEXICO 0.43%
Top 20 Economies (2013) and Percent of GDP Spent on R&D (2011)
Source: Scientific Americans, Sept. 2013
Economy Size
R&D Spending
Ⅰ
India / Brazil / Russia Mexico / Italy / Spain
Indonesia / Turkey Australia / Poland
Netherlands South Africa
U.S. / China / Japan / Germany / U.K. / France / Korea / Canada
Norway / Portugal Hungary / Luxembourg
New Zealand Argentina / Romania
Slovak Republic
Israel / Finland / Sweden / Denmark / Taiwan / Austria / Slovenia / Estonia / Singapore / Belgium / Czech Republic / Ireland
Ⅱ
Ⅲ Ⅳ